Literature DB >> 20532464

18F-fluoroethylcholine uptake in arterial vessel walls and cardiovascular risk factors: correlation in a PET-CT study.

S Förster1, A Rominger, T Saam, S Wolpers, K Nikolaou, P Cumming, M F Reiser, P Bartenstein, M Hacker.   

Abstract

AIM: Fluorine-labelled choline derivatives were recently suggested as agents for visualizing vulnerable atherosclerotic plaques. We therefore aimed to evaluate the association between18F-fluoroethylcholine (FEC) uptake in the wall of large arteries, where calcification was also measured, with the presence of cardiovascular risk factors and occurrence of prior cardiovascular events. PATIENTS,
METHODS: Detailed clinical information, including common cardiovascular risk factors, was obtained retrospectively in 60 prostate cancer patients examined with whole-body FEC PET-CT. In each patient, we calculated the mean blood pool-corrected SUV, as well as the mean target-to-background ratio (TBR), in addition to the sum of calcified plaques (CPsum) from six major vessels: ascending and descending aorta, aortic arch, abdominal aorta, and both iliac arteries.
RESULTS: As reported previously, the CPsum correlated significantly with cardiovascular risk factors, in contrast to mean SUV or TBR scores, which did not show any significance with the presence of cardiovascular risk factors. There was no correlation between CPsum, mean TBR or SUV, nor was there any significant association of CPsum, mean TBR or SUV with the prior occurrence of cardio- or cerebrovascular events.
CONCLUSION: Contrary to a recent report, we found in our rather large cohort of elderly prostate cancer patients no significant association between FEC uptake in large vessels and atherosclerotic plaque burden, or the presence of cardiovascular risk factors. In line with prior reports on structural changes in vessels, increased calcified atherosclerotic plaque burden was strongly associated with the occurrence of common cardiovascular risk factors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20532464     DOI: 10.3413/nukmed-0299

Source DB:  PubMed          Journal:  Nuklearmedizin        ISSN: 0029-5566            Impact factor:   1.379


  6 in total

Review 1.  PET imaging of aortic atherosclerosis: Is combined imaging of plaque anatomy and function an amaranthine quest or conceivable reality?

Authors:  Gary R Small; Terrence D Ruddy
Journal:  J Nucl Cardiol       Date:  2011-08       Impact factor: 5.952

2.  Imaging Immunometabolism in Atherosclerosis.

Authors:  Philip Z Mannes; Sina Tavakoli
Journal:  J Nucl Med       Date:  2021-05-07       Impact factor: 10.057

3.  68Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with18F-FDG, calcium burden and risk factors.

Authors:  Xiang Li; Samuel Samnick; Constantin Lapa; Ina Israel; Andreas K Buck; Michael C Kreissl; Wolfgang Bauer
Journal:  EJNMMI Res       Date:  2012-09-27       Impact factor: 3.138

Review 4.  Advances in Radiopharmaceutical Sciences for Vascular Inflammation Imaging: Focus on Clinical Applications.

Authors:  Kevin Prigent; Jonathan Vigne
Journal:  Molecules       Date:  2021-11-24       Impact factor: 4.411

5.  Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis.

Authors:  Jan Bucerius; Fabien Hyafil; Hein J Verberne; Riemer H J A Slart; Oliver Lindner; Roberto Sciagra; Denis Agostini; Christopher Übleis; Alessia Gimelli; Marcus Hacker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-17       Impact factor: 9.236

6.  Target identification for the diagnosis and intervention of vulnerable atherosclerotic plaques beyond 18F-fluorodeoxyglucose positron emission tomography imaging: promising tracers on the horizon.

Authors:  Jan Bucerius; Ingrid Dijkgraaf; Felix M Mottaghy; Leon J Schurgers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-09       Impact factor: 9.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.